Selecting antithrombotic therapy for patients with atrial fibrillation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25552627.
- Also identified by DOI 10.3949/ccjm.82a.140002 and PMC identifier 4444782.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When considering anticoagulant therapy for patients with atrial fibrillation, one must balance the reduction in risk of thromboembolism that this therapy offers against the risk of bleeding that it poses. The American Heart Association, American College of Cardiology, and Heart Rhythm Society updated their atrial fibrillation guidelines in 2014. This review outlines a rationale for clinical decision-making based on the new guidelines and summarizes the currently approved drugs.
Medical subject headings
- Atrial Fibrillation
- Fibrinolytic Agents